New Data in the Treatment of METex14-skipping Advanced NSCLC

F

Comparative Analysis of PFS & OS in 1L Treatment With Tepotinib vs. 1L IO+Chemo or IO Mono for METex14 Skipping NSCLC

By Frank Griesinger 3 Videos
128 views
August 2, 2024
Comments 0
Login to view comments. Click here to Login
17:51

WCLC 2024 Insights: Biology of CNS Metastases in NSCLC

Insights from 2024 WCLC

T. Burns

149 views
17:35

Strategies for Managing Toxicities of Oral Oncolytics in Lung Cancer…

UNC Lineberger Comprehensive Cancer Center

K. Chen, A. Faso, B. Patel

102 views
16:12

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

451 views
06:09

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

411 views
07:55

MET Exon 14 Skipping Mutations in NSCLC

MI&T Congressi

O. Gautschi

191 views
08:43

The VISION Trial: Tepotinib in Patients With NSCLC Harboring METex14…

Santiago Viteri

136 views
10:14

Precision Medicine in NSCLC

UChicago Medicine 12th International Clinical Cancer Genomics Conference

S. Gray

271 views
16:16

Clinical Insights on the Management of Edema Associated With MET Inh…

Lorenzo Belluomini

224 views